Finance

Lists
061250:KOSDAQ
Hwail Pharm Co Ltd
â‚©6,420.00
-0.16%
(-10.00) 1D
Sep 22, 3:30:03 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 061250...
Open
â‚©6,520
High
â‚©6,520
Low
â‚©6,310
Mkt. cap
54.04B
Avg. vol.
38.55K
Volume
18.16K
P/E ratio
11.19
52-wk high
â‚©13,800
52-wk low
â‚©943
EPS
â‚©574
Shares outstanding
8.42M
No. of employees
129
Open
â‚©6,520
High
â‚©6,520
Low
â‚©6,310
Mkt. cap
54.04B
Avg. vol.
38.55K
Volume
18.16K
P/E ratio
11.19
52-wk high
â‚©13,800
52-wk low
â‚©943
EPS
â‚©574
Shares outstanding
8.42M
No. of employees
129
About Hwail Pharm Co Ltd
CEO-
Employees129
Founded1974
Headquarters-
SectorPharmaceutical industry
Websitehwail.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Dec 2015
Jun 2025
Mar 2026
Jun 2026
Revenue
-
27.96B
23.44B
24.46B
Cost of goods sold
-
25.98B
21.10B
22.50B
Cost of revenue
-
25.98B
21.10B
22.50B
Research and development expenses
-
170.40M
161.44M
171.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
1.88B
2.33B
2.24B
Operating expense
-
1.85B
2.91B
2.87B
Total operating expenses
-
27.84B
24.01B
25.38B
Operating income
-
120.91M
-565.65M
-912.07M
Other non operating income
-
494.99M
78.32M
148.69M
EBT including unusual items
-
686.54M
762.24M
5.76B
EBT excluding unusual items
-
571.36M
407.34M
-770.54M
Income tax expense
-
135.05M
183.25M
1.38B
Effective tax rate
-
19.67%
24.04%
24.04%
Other operating expenses
-
22.59M
90.92M
16.17M
Net income
-
551.48M
578.99M
4.37B
Net profit margin
-
1.97%
2.47%
17.88%
Earnings per share
-
-
-
-
Interest and investment income
-
233.62M
259.78M
259.06M
Interest expense
-
-99.25M
-3.42M
-3.14M
Net interest expenses
-
134.38M
256.36M
255.92M
Depreciation and amortization charges
-
151.07M
272.11M
276.64M
EBITDA
-
476.60M
-293.54M
-506.63M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps